BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21077340)

  • 1. [Diabetic nephropathy and nephrotic syndrome].
    Wada T
    Nihon Jinzo Gakkai Shi; 2010; 52(7):908-13. PubMed ID: 21077340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment recommendations for various stages in diabetic nephropathy].
    Takane H; Suzuki H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():379-83. PubMed ID: 15999738
    [No Abstract]   [Full Text] [Related]  

  • 3. [Management of diabetic nephropathy with nephrotic syndrome].
    Eguchi J; Wada J; Makino H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():430-6. PubMed ID: 12430265
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diabetic nephropathies].
    Makino H
    Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():49-66. PubMed ID: 17899828
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progress on diagnosis and therapy of diabetic nephropathy].
    Kitsukawa R
    Nihon Naika Gakkai Zasshi; 1996 Apr; 85(4):546-50. PubMed ID: 8708472
    [No Abstract]   [Full Text] [Related]  

  • 6. [Urinary type IV collagen as a biological marker for diagnosis of diabetic nephropathies].
    Araki S
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():362-6. PubMed ID: 15999735
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diabetic nephropathy].
    Koya D; Kashiwagi A
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():625-9. PubMed ID: 15779451
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early diagnosis of and therapy for patients with diabetic nephropathy].
    Makino H
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):471-6. PubMed ID: 15052805
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nephrotic syndrome due to metabolic disease--special reference to diabetic nephropathy].
    Ohga S; Shikata K; Makino H
    Nihon Rinsho; 2004 Oct; 62(10):1907-13. PubMed ID: 15500138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early diagnosis and therapy of diabetic nephropathy].
    Shigeta Y
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):464-7. PubMed ID: 8691016
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetic nephropathy--manage now!].
    Ritz E
    Dtsch Med Wochenschr; 2010 Mar; 135(9):p8. PubMed ID: 20200822
    [No Abstract]   [Full Text] [Related]  

  • 13. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
    Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases].
    Esnault V
    Nephrol Ther; 2006 May; 2 Suppl 3():S193-6. PubMed ID: 17370850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guidelines for the treatment of nephrotic syndrome].
    Japanese Society of Nephrology
    Nihon Jinzo Gakkai Shi; 2011; 53(2):78-122. PubMed ID: 21516692
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetic nephropathy: common questions.
    Thorp ML
    Am Fam Physician; 2005 Jul; 72(1):96-9. PubMed ID: 16035688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renoprotective effects of ACE inhibitors and AT1 antagonists on diabetic nephropathy beyond blood pressure control].
    Shionoiri H; Yasuda G; Takizawa T; Shionoiri F
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():394-9. PubMed ID: 15999741
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular disease and CKD: core curriculum 2010.
    Shastri S; Sarnak MJ
    Am J Kidney Dis; 2010 Aug; 56(2):399-417. PubMed ID: 20599309
    [No Abstract]   [Full Text] [Related]  

  • 19. The kidney and the eye in people with diabetes mellitus.
    Agarwal SK; Venkatesh P; Tandon N
    Natl Med J India; 2008; 21(2):82-9. PubMed ID: 18807316
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of angiotensin receptor blockers on myocardial infarction: what are we to believe?
    Ker JA; Rheeder P
    Cardiovasc J S Afr; 2005; 16(2):81-2. PubMed ID: 15915272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.